Hemostasis Products Market Size & Share, by Product (Topical, Infusible, Advanced); Application (Trauma, Surgery, Hemophilia, Myocardial Infarction); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4447
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Hemostasis Products Landscape

    • Terumo Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Baxter International, Inc.
    • Sysmex Asia Pacific Pte Ltd
    • Abbott Healthcare Private Limited
    • csl behring llc
    • Grifols, S.A.
    • Dexur Inc
    • Pfizer Inc.
    • Tricol Biomedical.
    • Medtronic plc

Browse Key Market Insights with Data Illustration:


In The News

  • In order to accelerate and expand its product portfolio, Grifols, S.A. has completed the acquisition of 100% of the stock capital of Tiancheng Pharmaceutical Holdings AG.

  • A new product line for advanced surgery has been added to the Baxter International, Inc. portfolio with the acquisition of the PerClot Polysaccharide Hemostatic System.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4447
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of cardiovascular diseases, huge base of geriatric population along with increasing blood clotting disorders are the major factors driving the growth of the hemostasis products market.

The market is anticipated to attain a CAGR of 5.1% over the forecast period, i.e., 2023-2033.

Inadequacy of surgical professionals and high cost of product are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Terumo Corporation, Baxter International, Inc., Sysmex Asia Pacific Pte Ltd, Abbott Healthcare Private Limited, csl behring llc, Grifols, S.A., Dexur Inc, Pfizer Inc., Tricol Biomedical., Medtronic plc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end user and, by region.

The topical hemostasis products is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying